The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 201 through 210 of 402 results (Download Results)

Show results per page

Characterization of interferon-lambda 1 as a treatment for COVID-19

Tyrrell, D. Lorne J | University of Alberta | Operating Grant | $499,775

CIHR Alberta 2020

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Lewis, John D | University of Alberta | Operating Grant | $4,225,000

CIHR Alberta 2020

Development of safe and effective vaccines against COVID-19

Liu, Jun | University of Toronto | Operating Grant | $416,483

CIHR Ontario 2020

Countermeasures to the supply chain disruptions in medical and pharmaceutical industries

Toyasaki, Fuminori | York University | Operating Grant | $130,600

CIHR Ontario 2020

Combating misinformation, fear and stigma in response to the Covid-19 outbreak: An international collaboration between Canada and Singapore

Fahim, Christine | Unity Health Toronto | Operating Grant | $499,965

CIHR Ontario 2020

Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND

Prystajecky, Natalie Anne | University of British Columbia | Operating Grant | $1,000,000

CIHR British Columbia 2020

Personality as a predictor of emerging adults’ poor adherence and psychological distress to public health measures for controlling COVID‑19 viral spread: Empirical evidence and intervention efficacy

Stewart, Sherry H | Dalhousie University | Operating Grant | $200,000

CIHR Nova Scotia 2020

Ethical Pathways for Therapeutics and Vaccine R&D in the Context of Public Health Emergencies of International Concern: An Analysis of the 2013-16 Ebola Outbreak to Rapidly Inform COVID‑19 R&D

Smith, Maxwell | Western University | Operating Grant | $283,656

CIHR Ontario 2020

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $172,414

CIHR British Columbia 2020

Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)

Gatignol, Anne | Lady Davis Institute for Medical Research | Operating Grant | $360,377

CIHR Quebec 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Characterization of interferon-lambda 1 as a treatment for COVID-19

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Development of safe and effective vaccines against COVID-19

Countermeasures to the supply chain disruptions in medical and pharmaceutical industries

Combating misinformation, fear and stigma in response to the Covid-19 outbreak: An international collaboration between Canada and Singapore

Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND

Personality as a predictor of emerging adults’ poor adherence and psychological distress to public health measures for controlling COVID‑19 viral spread: Empirical evidence and intervention efficacy

Ethical Pathways for Therapeutics and Vaccine R&D in the Context of Public Health Emergencies of International Concern: An Analysis of the 2013-16 Ebola Outbreak to Rapidly Inform COVID‑19 R&D

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)